Randomized controlled trial of an oral Gastrin Receptor Antagonist for the treatment of postmenopausal osteoporosis

医学 内科学 胃泌素 骨质疏松症 内分泌学 骨重建 耐受性 质子抑制剂泵 随机对照试验 胃肠病学 萎缩性胃炎 骨密度 方差分析 受体拮抗剂 敌手 胃蛋白酶 口服 代理终结点 重复措施设计 临床终点 绝经后妇女 置信区间 骨矿物 绝经后骨质疏松症 胃 骨病
作者
Marian Schini,Fatma Gossiel,Margaret A. Paggiosi,Sara L Hilditch,Stuart More,Irvin Modlin,Richard Eastell
出处
期刊:Journal of Bone and Mineral Research [Oxford University Press]
标识
DOI:10.1093/jbmr/zjaf165
摘要

Abstract High gastrin levels may help explain the association between several conditions and osteoporosis, such as pernicious anaemia, the use of proton pump inhibitors, and atrophic gastritis. This study aimed to determine whether administering a gastrin receptor antagonist (GRA) to older women would lower their bone turnover markers and, therefore, be a suitable preventive measure for osteoporosis. We conducted a randomised, double-blind, placebo-controlled clinical trial to assess the efficacy, safety, and tolerability of an oral GRA (netazepide) 100 mg administered daily for 90 days in postmenopausal women. Our primary endpoint was the change in the bone turnover marker (BTM) plasma CTX (automated immunoassay analyser) at days 0, 7, 28, 56, and 90. We also measured other BTMs, and gastrin and group I pepsinogens (ELISA assays). We studied the effect of the drug on the log-transformed baseline scaled ratio for bone turnover marker and gastric markers using mixed-model ANOVA for the fixed effects of treatment, time, and the treatment-by-time interaction, with the baseline value included as a covariate. We studied 99 women, with a mean age of 60 years and BMD T- scores for the spine and total hip of -0.96 and -0.09, respectively. We found that gastrin increased by 90% in response to GRA as early as 7 days (p-value for treatment 0.0008), and group I pepsinogens decreased by 15% as early as 7 days (p-value 0.0002). There was no significant change in plasma CTX. A high percentage of women (81/99) completed the study, and the GRA was well tolerated. GRA had the expected effects on the gastric markers with an increase in gastrin and a decrease in group I pepsinogens. However, the absence of any change in the bone resorption marker plasma CTX was a bit surprising. Based on this study it appears that short term gastrin receptor antagonism is unlikely to be a successful strategy in the prevention of osteoporosis. However, this a preliminary exploration of a novel hypothesis and larger studies might be needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
星辰大海的应助被淡然的宛秋采纳,获得10
2秒前
2秒前
万能图书馆的应助被衣美竹采纳,获得10
3秒前
UPC_ZZM完成签到,获得积分10
3秒前
3秒前
小懒完成签到,获得积分10
4秒前
WZH完成签到,获得积分10
5秒前
5秒前
传奇3的应助被ay采纳,获得10
5秒前
skper发布了新的文献求助10
6秒前
6秒前
6秒前
小二郎的应助被niko采纳,获得10
6秒前
tomatoGG发布了新的文献求助10
6秒前
7秒前
llllllll关注了科研通微信公众号
8秒前
zhangzhen发布了新的文献求助10
8秒前
8秒前
mm的应助被甜甜天德采纳,获得10
8秒前
8秒前
8秒前
wmz完成签到,获得积分10
9秒前
梦寐寤寐发布了新的文献求助10
9秒前
10秒前
丘比特的应助被温暖砖头采纳,获得10
10秒前
10秒前
10秒前
斯文败类的应助被逆流而上采纳,获得10
11秒前
时尚的诗珊完成签到,获得积分10
12秒前
秋风的应助被徐枘采纳,获得10
12秒前
12秒前
传奇3的应助被如意2023采纳,获得10
13秒前
nn完成签到,获得积分10
13秒前
liuliu发布了新的文献求助10
13秒前
十一发布了新的文献求助10
14秒前
yyy发布了新的文献求助10
15秒前
酷波er的应助被淡然的宛秋采纳,获得10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193335
求助须知:如何正确求助?哪些是违规求助? 9579489
关于积分的说明 21865844
捐赠科研通 7792843
什么是DOI,文献DOI怎么找? 3437210
关于科研通互助平台的介绍 2560687
邀请新用户注册赠送积分活动 2483996